APA (7th ed.) Citation

HJ, Y., YS, S., JH, K., W, K., YK, J., JY, J., . . . JM, Y. (2025). Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial. Clinical and molecular hepatology, 31(3), 810. https://doi.org/10.3350/cmh.2024.0819

Chicago Style (17th ed.) Citation

HJ, Yim, et al. "Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial." Clinical and Molecular Hepatology 31, no. 3 (2025): 810. https://doi.org/10.3350/cmh.2024.0819.

MLA (9th ed.) Citation

HJ, Yim, et al. "Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial." Clinical and Molecular Hepatology, vol. 31, no. 3, 2025, p. 810, https://doi.org/10.3350/cmh.2024.0819.